Nanotechnology and medicine

Expert Opinion on Biological Therapy

Volumn 3, Issue 4, 2003, Pages 655-663

  Emerich, Dwaine F ^a   Thanos, Christopher G ^b  

^a Sertoli Technologies Incorporated   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Drug delivery; Encapsulation; Gene therapy; Nanotechnology; Tissue engineering

Indexed keywords

CHEMICAL ANALYSIS; CLINICAL MEDICINE; COST EFFECTIVENESS ANALYSIS; DEVICE; DNA SEQUENCE; DRUG DELIVERY SYSTEM; GENE THERAPY; INTERPERSONAL COMMUNICATION; NANOTECHNOLOGY; QUALITY OF LIFE; REVIEW; ROBOTICS; SURFACE PROPERTY; TISSUE ENGINEERING;

ANIMALS; DIAGNOSIS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GENE THERAPY; HUMANS; MEDICINE; NANOTECHNOLOGY; RECEPTORS, DRUG; SEQUENCE ANALYSIS, DNA; TISSUE ENGINEERING;

EID: 0037926875     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.3.4.655     Document Type: Review

References (66)

1. FEYNMAN R: Engineering and Science. (California Institute of Technology) (1959). Interesting historical lecture that provided the vision of nanotechnology.
2. SMALLEY RE: United States House testimony. June 22, 1999.
3. SEEMAN N: DNA engineering and its application to nanotechnology. Trends Biotechnol. (1999) 17:437-443.
4. MAO C, THALLADI V, WOLFE D et al.: Dissections: self-assembled aggregates that spontaneously reconfigure their structures when their environment changes. J. Am. Chem. Soc. (2002) 124:14508-14509. Important demonstration of the ability to develop systems capable of self-assembly and responding to external stmuli
5. YURKE B, TURBERFIELD AJ, MILLS AP, SIMMEL FC, NEUMANN JL: A DNA-fueled molecular machine made of DNA. Nature (2000) 406:605-608.
6. MONTEMAGNO CD, BACHAND GD: Constructing nanomechanical devices powered by biomolecular motors. Nanotechnology (1999) 10:225-231.
7. BACHAND GD, MONTEMAGNO CD: Constructing organic/inorganic NEMS devices powered by biomolecular motors. Biomed. Microdev. (2000) 2:179-184.
8. WU H, THALLIDI V, WHITESIDES S et al.: Using hierarchical self-assembly to form three-dimensional lattices of spheres. J. Am. Chem. Soc. (2002) 124:14495-14502.
9. KIM P, LIEBER C: Nanotube nanotweezers. Science (1999) 286:2148-2150. Pioneering study of manipulation at the atomic level
10. CLARK H, KOPELMAN R, TJALKENS R et al.: Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors. Anal. Chem. (1999) 71:4837-4843.
11. SUMNER JP, AYLOTT JW, MONSON E, KOPELMAN R: A fluorescent PEBBLE nanosensor for intracellular free zinc. Analyst (2002) 127:11-16.
12. WUNDERBALDINGER P, JOSEPHSON L, WEISSLEDER R: Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug. Chem. (2002) 13:264-268.
13. CSAKI A, MOLLER R, FRITZSCHE W: Gold nanopartides as novel label for DNA diagnostics. Expert Rev. Mol. Diagn. (2002) 2:187-193.
14. BARATHUR R, BOOKOUT J, SREEVATSAN S et al.: New disc-based technologies fot diagnostic and research applications. Psychiatr. Genet. (2002) 12:193-206.
15. MCSHANE M: Potential for glucose monitoring with nanoengineered fluorescent biosensors. Diabetes. Technol. Ther. (2002) 4:533-538.
16. LANZA GM, WALLACE KD, SCOTT MJ et al.: A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation (1996) 94:3334-3340.
17. LANZA GM, TROUSIL RL, WALLACE KD et al.: In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J. Acoust. Soc. Am. (1998) 104:3665-3672.
18. WICKLINE SA, LANZA GM: Nanotechnology for molecular imaging and targeted therapy. Circulation (2003) 107:1092-1095.
19. LANZA GM, LORENZ CH, FISCHER SE et al.: Enhanced detection of thrombi with a novel fibrin targeted magnetic resonance imaging agent. Acad. Radiol. (1998) 5(Suppl. 1):S173-S176.
20. ANDERSON SA, RADER RK, WESTLIN WF et al.: Magnetic resonance contrast enhancement of neovascular with v3-targeted nanoparticles. Magn. Reson. Med. (2000) 44:433-439.
21. LANZA GM, ABENDSCHEIN DR, HALL CS et al.: Molecular imaging of stretch induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest. Radiol. (2000) 35:227-234.
22. YU X, SONG S-K, CHEN J et al.: High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanopartide contrast agent. Magn. Reson. Med. (2000) 44:867-872.
23. FLACKE S, FISCHER S, SCOTT MJ et al.: Novel MRI contrast agent for molecular imaging of fibrin Implications for detecting vulnerable plaques. Circulation (2001) 104:1280-1285.
24. LANZA GM, YU X, WINTER PM et al.: Targeted antiproliferative drug delivery to vascular smooth muscle cells with magnetic resonance imaging nanopartide contrast agent: implications for rational therapy of testenosis. Circulation (2002) 106:2842-2847.
25. SHI H, RATNER B: Template recognition of ptotein-imprinted polymer surfaces. J. Biomed. Mater. Res. (2000) 49:1-11.
26. NISHIZAWA M, MENON VP, MARTIN CR: Metal nanotubule membranes with electrochemically switchable ion-transport selectivity. Science (1995) 268:700-702.
27. MELLER A, NIVON L, BRANDIN E et al.: Rapid nanopore discrimination between single polynudeotide molecules. Proc. Natl. Acad. Sci. USA (2000) 97:1079-1084.
28. HOWORKA S, CHELEY S, BAYLEY H: Sequence-specific detection of individual DNA strands using engineered nanopores. Nat. Biotech. (2001) 19:636-639.
29. DEAMER DW, AKESON M: Nanopores and nucleic acids: prospects for ultrarapid sequencing. Trends Biotech. (2000) 18:147-151.
30. COHEN S, YOSHIOKA T, LUCARELLI M et al.: Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. (1992) 8:713-720.
31. MATHIOWITZ E, JACOB J, JONG Y et al.: Biologically erodable microspheres as potential oral drug delivery systems. Nature (1997) 386:410-414. Important advancements in nanosphere technology.
32. HILLYER J, ALBRECHT R: Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci. (2001) 90:1927-1936.
33. TORCHE A, JOUAN H, CORRE PL et al.: Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment. Int. J. Pharm. (2000) 201:15-27.
34. LUBBEN IVD, KONINGS F, BORCHARD G et al.: In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J. Drug Target. (2001) 9:39-47.
35. HUSSAIN N, JAITLEY V, FLORENCE A: Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug Deliv. Rev. (2001) 50:107-142. Detailed review on intestinal translocation.
36. LUTSIAK M, ROBINSON D, COESTER C et al.: Analysis of poly(D,L-lactic-co-ctycolic acid) nanosphere uptake by human dendritic cells and mactophages in vitro. Pharm. Res. (2002) 19:1480-1487.
37. BUSTAMI R, CHAN H, DEHGHANI F et al.: Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide. Pharm. Res. (2000) 17:1360-1366.
38. LOSCERTALES I, BARRERO A, GUERRERO I et al.: Micro/nano encapsulation via electrified coaxial liquid jets. Science (2002) 295:1695-1698.
39. LIU L, ZERN M, LIZARZABURU M et al.: Poly(cationic lipid)-mediated in vivo gene delivery to mouse liver. Gene Ther. (2003) 10:180-187.
40. ZHANG Y, SCHLACHETZKI F, PARDGRIDGE W: Global non-viral gene transfer to the primate brain following intravenous administration. Mol. Ther. (2003) 7:11-18.
41. COHEN-SACKS H, NAJAJREH Y, TCHAIKOVSKI V et al.: Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis. Gene Ther. (2002) 9:1607-1616.
42. BERTON M, TURELLI P, TRONO D et al.: Inhibition of HIV-1 in cell culture by oligonucleodde-loaded nanoparticles. Pharm. Res. (2001) 18:1096-1101.
43. PEREZ C, SANCHEZ A, PUTNAM D et al.: Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J. Cont. Rel. (2001) 75:211-224.
44. KUKOWSKA-LATALLO J, RACSKA E, QUINTANA A et al.: Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Hum. Gene Ther. (2000) 11:1385-1395.
45. MAKSIMENTO A, MANDROGLJINE V, GOTTIKH M et al.: Optimisation of dendrimer-mediated gene transfer by anionic oligomers. J. Gene Med (2003) 5:61-71.
46. SANTINI J, CIMA M, LANGER R: A controlled-release microchip. Nature (1999) 397:335-338. Merging drug delivery and computer technology.
47. MARTIN C, KOHLI P: The emerging field of nanotube biotechnology. Nat. Rev. Drug Discov. (2002) 2:29-35.
48. GOLDSTEIN A, AMORY J, MARTIN S et al.: Testosterone delivery using glutamide-based complex high axial ratio microstructures. Bioorgan. Med. Chem. (2001) 9:2819-2825.
49. CHEN R, ZHANG Y, WANG D et al.: Noncovalent sidewall functionalization of single-wahed carbon nanotubes for protein immunobilization. J. Am. Chem. Soc. (2001) 123:3838-3839.
50. THOMPSON D, BEUTTNER H: Schwann cell response to micropatterned laminin surfaces. Tissue Eng. (2001) 7:247-265.
51. LEE C, HUIE P, LENG T et al.: Microcontact printing on human tissue for retinal cell transplantation. Arch. Ophthalmol. (2002) 120:1714-1718.
52. ROUXHET L, DUHOUX F, BORECKY O et al.: Adsorption of albumin, collagen, and fibronectin on the surface of poly(hydroxybutyrate-hydroxyvalerate) (PHB/HV) and of poly (epsilon-caprolactone) (PCL) films modified by an alkaline hydrolysis and of poly(ethylene terephtalate) (PEI) tracketched membranes. J. Biomater. Sci. Polym. Ed. (1998) 9:1279-1304.
53. MAHESHWARI G, BROWN G, LAUFFENBERGER D et al.: Cell adhesion and motility depend on nanoscale RGD clustering. J. Cell Sci. (2000) 113:1677-1686.
54. IRVINE D, RUZETTE A, MAYES A et al.: Nanoscale clustering of RGD peptides at surfaces using comb polymers. 2. Surface segregation of comb polymers in polylactide. Biomacromolecules (2001) 2:545-556.
55. DU C, CUI F, ZHU X et al.: Three-dimensional nano-HAp/collagen matrix loading with osteogenic cells in organ culture. J. Biomed. Mater. Res. (1999) 44:407-415.
56. ZHANG R, MA P: Synthetic nano-fibrillar extracellular matrices with predesigned macroporous architectures. J. Biomed. Mater. Res. (2000) 52:430-438.
57. FOLCH A, JO B, HURTADO O et al.: Microfabricated elastomeric stencils for micropatterning cell cultures. J. Biomed. Maten. Res. (2000) 52:346-353.
58. CANS A, WITTENBERG N, KARLSSON R et al.: Artificial cells: unique insights into exocytosis using liposomes and lipid nanotubes. Proc. Nat. Acad. Sci. USA (2003) 100:400-404.
59. SIPKINS DA, CHERESH DA, KAZEMI MR et al.: Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat. Med. (1998) 4:623-626.
60. HUANG S, HAMILTON AJ, TIUKINHOY SD et al.: Liposomes as ultrasound imaging contrast agents and as ultrasound-sensitive drug delivery agents. Cell Mol. Biol. Lett. (2002) 7:233-235.
61. BULTE JW, DUNCAN ID, FRANK JA et al.: In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J. Cereb. Blood Flow Metab. (2002) 22:899-907.
62. RONDEROS RE, BOSKIS M, CHUNG N et al.: Correlation between myocardial perfusion abnormalities with intermittent imaging using intraveneous perfluorocarbon microbubbles and radioisotope imaging during high-dose dipyridamole stress echo. Clin. Cardiol. (2002) 25:103-111.
63. FRENKEL PA, CHEN S, THAI T, SHOHET RV, GRAYBURN PA: DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med. Biol. (2002) 28:817-822.
64. UNGER EC, MATSUNAGA TO, MCCREERY T et al.: Therapeutic applications of microbubbles. Eur. J. Radiol. (2002) 42:160-168.
65. http://www.quantumdot.com Quantum Dot Corporation.
66. http://www.acusphere.com/ab_5.html WALOVITCH R, KWAN O, PICARD M et al.: Initial safety and myocardial perfusion imaging results with AI-700: a new ultrasound contrast agent. Acusphere, Inc., (2003).